Inmune Bio Inc (INMB) has shared an announcement.
INmune Bio Inc. has greenlit the issuance of stock options to its non-employee directors and select executives, including the CEO and CFO, under their 2021 Stock Incentive Plan, with options exercisable at $9.92 per share. These options will vest incrementally over a period of one to four years, providing an incentive for long-term investment in the company’s growth. The granted options are set to expire in 2034, reflecting the company’s commitment to its leadership team and their sustained contribution to its success.
For a thorough assessment of INMB stock, go to TipRanks’ Stock Analysis page.
